Vivek Kumar

37.3k citations

63 papers · 1.1k indexed · 1 hit paper · h-index 16

Impact in

Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Oncology 24
- Cancer Immunotherapy and Biomarkers 6
- Viral-associated cancers and disorders 5
Genetics 7
- Chronic Lymphocytic Leukemia Research 4

Co-authors: Abhinav Chandra Mohit Garg Parita Soni Neha Chaudhary Charalampos S. Floudas Osama E. Rahma Helmut G. Rennke Atul B. Shinagare
Journals: Journal of Prosthodontics (2 papers)BMC Cancer (2 papers)European Journal of Gastroenterology & Hepatology (2 papers)Frontiers in Oncology (2 papers)Frontiers in Pharmacology (2 papers)
Partner nations: United States India Canada

In The Last Decade

Vivek Kumar

56 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy 2017 · 465 citations

Peers

Countries citing papers authored by Vivek Kumar

Since Specialization

Citations

This map shows the geographic impact of Vivek Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Kumar more than expected).

Fields of papers citing papers by Vivek Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Kumar. The network helps show where Vivek Kumar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vivek Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vivek Kumar Line = papers co-authored together Vivek Kumar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1733P Update on gallant: A phase II study using metronomic gemcitabine, doxorubicin and docetaxel plus nivolumab in previously treated sarcoma Annals of Oncology ·Neal Shiv Chawla, Hervé Allei, Vivek Kumar, Jennifer Nevin, Stefanie S. Jeffrey, Gloria Royo Gómes, Jianqiamg Liamg, فرشاد صفرپور, Thums, O I Sharavova, Aguilar Matas J, Erlinda M. Gordon	2024	1
2	The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy Frontiers in Oncology ·Yiqing Xu, Tan Zong-lian, Yunhong Wu, Franz Muheim, Joon H. Jang, Charles Garcia, Thi Thanh Hoa Tieu, A. A. ZAVALETA, Vivek Kumar	2024	1
3	Immune Checkpoint Inhibitors in Metastatic Bladder and Other Solid Malignancies: How Long is Enough? Bladder Cancer ·Vivek Kumar, Xiao X. Wei	2023	2
4	Online Food Delivery System in India: Profile of Restaurants and Nutritional Value of Food Items Vision The Journal of Business Perspective ·Rizwan Suliankatchi Abdulkader, Kathiresan Jeyashree, Vivek Kumar, K. Senthamarai Kannan, V. Deneshkumar	2022	4
5	Quality of Life with the Rehabilitation After Partial Mandibulectomy: a Systematic Review Indian Journal of Surgical Oncology ·Theresa Southam, 愛媛宇和島地区広域事務組合消防本部, Vivek Kumar	2022	0
6	Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes Clinical Genitourinary Cancer ·Matthew Mossanen, Amin H. Nassar, Howard Elbaum, Nieves Martínez Chanzá, Vivek Kumar, Pier Vitale Nuzzo, David J. Kwiatkowski, Judy E. Garber, Catherine Curran, Dory Freeman, Mark A. Preston, Kent W. Mouw, Adam S. Kibel, Toni K. Choueiri, Guru Sonpavde, Huma Q. Rana	2022	5
7	The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature The Oncologist ·Vivek Kumar, Atul B. Shinagare, Helmut G. Rennke, Sandeep Ghai, Jochen H. Lorch, Patrick A. Ott, Osama E. Rahma	2020	104
8	Oral manifestation and its management in postmenopausal women:an integrated review Menopausal Review ·Suman Sen, Антон С. Ширкунов, Abhijit Dutta, Touria Bouhafa, Vivek Kumar, Kim Jung Yeoul	2020	14
9	Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis Scientific Reports ·Vivek Kumar, Neha Chaudhary, Maureen M. Achebe	2020	23
10	Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis Clinical Lymphoma Myeloma & Leukemia ·Vivek Kumar, P. S. Seethal1, Dr. S. Sreeja2, S. Risana Nizar*3, M. Hiba4, S. S. Riyan5, José Antonio Pérez Vicente, C. Ullgren, Chander Shekher Aggarwal, 原正道, Sinem Yigit, Vivek Roy, Taimur Sher, Victoria R. Alegria, Aneel Paulus, Asher Chanan‐Khan, Sikander Ailawadhi	2020	22
11	Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia Blood Cancer Journal ·Vivek Kumar, Sikander Ailawadhi, Aaron Damien. Berger, Aditya Mehta, Tommaso Pajero, Taimur Sher, Vivek Roy, Prakash Vishnu, Julian A. Marin‐Acevedo, Victoria R. Alegria, Aneel Paulus, Raj Chand, Madiha Iqbal, Rami Manochakian, Winston Tan, Asher Chanan‐Khan, P. S. Seethal1, Dr. S. Sreeja2, S. Risana Nizar*3, M. Hiba4, S. S. Riyan5	2019	44
12	Racial disparities in incidence & survival of Kaposi's sarcoma in the United States The Indian Journal of Medical Research ·Vivek Kumar, Parita Soni, Mohit Garg, Michael C. Neubert, Abhinav Chandra	2019	9
13	An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States PeerJ ·Vivek Kumar, Mohit Garg, Neha Chaudhary, Abhinav Chandra	2018	15
14	Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma Clinical Lymphoma Myeloma & Leukemia ·Vivek Kumar, Mohit Garg, Abhinav Chandra, Cylus, Salman Ahmed, Sikander Ailawadhi	2018	10
15	A Comparative Study of Primary Adenoid Cystic and Mucoepidermoid Carcinoma of Lung Frontiers in Oncology ·Vivek Kumar, Parita Soni, Mohit Garg, Abhishek Goyal, 均森岡, Stephan L. Kamholz, Abhinav Chandra	2018	20
16	Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients BMC Cancer ·Jasmine Lee, 蒋丽妍, G.D. Mikailov, Eric Dornoff, Bradley C. Clark, Zhiheng Meng, Vivek Kumar, Franz Muheim, Khin Than Win, Yiwu Huang, Yiqing Xu	2017	14
17	The performance of NLST screening criteria in Asian lung cancer patients BMC Cancer ·Vivek Kumar, William F. Romain, F. Gill, Yiwu Huang, Yiqing Xu	2015	9
18	Cheek Bumper Prosthesis for a Patient with a Neurofibromatous Lesion in the Left Cheek Journal of Prosthodontics ·Kyu ho 이규호Lee, Vivek Kumar, T. V. Padmanabhan, V. V. Kuraev, Ngọc Trụ Vũ	2012	2
19	Prosthetic Rehabilitation of a Maxillectomy with a Two-Piece Hollow Bulb Obturator. A Clinical Report Journal of Prosthodontics ·T. V. Padmanabhan, Vivek Kumar, Marina Schmidt, 李萌 LI Meng	2011	15
20	Fabrication of temporary speech bulb prosthesis: A clinical report The Journal of Indian Prosthodontic Society ·Marina Schmidt, Vivek Kumar, Hamida Hasan, Tatiana Rosa Carvalho Ribeiro	2010	2

About Vivek Kumar

Vivek Kumar is a scholar working on Oncology, Genetics, Medical Laboratory Technology, Hematology and Pathology and Forensic Medicine, having authored 63 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Multiple Myeloma Research and Treatments (5 papers), Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Renal cell carcinoma treatment (3 papers), Reconstructive Facial Surgery Techniques (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Oncology (733 citations), Hepatology (98 citations), Pathology and Forensic Medicine (205 citations), Genetics (118 citations) and Transplantation (24 citations). Vivek Kumar has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Abhinav Chandra, Mohit Garg, Parita Soni, Neha Chaudhary, Charalampos S. Floudas, Osama E. Rahma, Helmut G. Rennke, Atul B. Shinagare, Jochen H. Lorch and Patrick A. Ott. Their work appears in journals such as Journal of Prosthodontics, BMC Cancer, European Journal of Gastroenterology & Hepatology, Frontiers in Oncology and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact